sdph
6 년 전
To whom it may concern:
Anyone wishing to know the where abouts of Michelle Rico...aka...CEO of Proto Script Pharmaceutical Corp. might want to look here...LINKEDIN....
https://www.linkedin.com/in/michelle-rico-01749935/
I actually got her to respond twice to messages I sent to her, quite to my surprise I might add !!
Anyways, I have been pestering her for an answer to the allegations as to ...
"PSCR named in SEC dispatches on Otcober 2nd as one of the tickers involved in a share selling scam orchestrated by Roger Knox and his buddies."
I seriously doubt that I will get a response from her, but I was "bold" enough to give her both of my email addresses to respond to , just to let her know that I am a real person, "investor", and am not hiding behind any desk or alias, whatever the case may be.
I am leaving this info for all to see, and to respond to her as well. Just might get some response if we all message her,who knows ?
Anyways, thanks for your eyes, and lets hope PSCR will come out with some sort of PR to give investors some kind of affirmation that they are moving ahead with their business, and not getting "shanked" like very many of us were with "TRBO" stock..
sdph signing out....
sdph
7 년 전
I've been watching from the bleachers on this stock for a while, and, I've also been holding this stock for way over a year now, and am really surprised it has had no current news as of late other that it's SEC filings ??
BarCharts does not even list it in their charts?
If anyone else is getting the same results, I would like to know if there is something going on that we all need to be aware of, or it is just a malingering stock waiting to hit ??
scaptrader1297
7 년 전
yes, can move quick,, but, this company hasn't put out any pr or news at all as to a contract, any new business anything?? I am hoping for a block chain pr from them....lmao>> anyway, any news would help..
news sniffer outer
8 년 전
PSCR ~ NEWS!!!
March 10, 2017 11:45 ET
Proto Script Pharmaceutical Corp. Completes Previously Announced Share Structure Improvements
RANCHO CUCAMONGA, CA--(Marketwired - Mar 10, 2017) - Proto Script Pharmaceutical Corp. dba PSP Homecare ("PSP" or the "Company") (OTC PINK: PSCR), a durable medical equipment provider, is pleased to announce it has completed the previously announced exchange of 295,000,000 shares of its common stock for 1,500,000 newly issued multiple-voting convertible Preferred Series A shares.
As result of the definitive Share Exchange Agreement between the Company and Michelle Rico, the Company's president and PSP Homecare founder, 295,000,000 shares of restricted common stock held by Michelle Rico were exchanged for 1,500,000 newly issued multiple-voting convertible Preferred Series A shares. Preferred Series A shares are convertible into twenty (20) common shares each and are entitled to 200 votes per share. Common shares issuable via Preferred Series A conversion remain restricted. To date, Michelle Rico has sold no shares of PSCR common or preferred stock.
Following the share exchange, as of Feb. 23, 2017, there are 49,139,998 shares of PSCR common stock and 1,500,000 shares of Preferred Series A stock outstanding. This represents an 85% reduction in the number of shares of PSCR common stock outstanding compared to prior to the share exchange. If converted, on a fully diluted basis, the 1,500,000 Preferred Series A shares would represent an additional 30,000,000 PSCR common shares (20 for 1 conversion ratio) bringing the total outstanding common shares to 79,139,998. This would still represent a significant 76% reduction in the number of PSCR common shares outstanding compared to prior to the share exchange.
The current number of outstanding PSCR common shares (49,139,998) has been verified by the Company's transfer agent, as indicted in the Company's OTC Markets Profile at www.otcmarkets.com/stock/PSCR/profile.
Additional information regarding PSP Homecare can be found at www.psphomecare.com.
sinclair8
8 년 전
With all due respect, being contracted with Medicaid and/or Medicare, while of value doesn't equate to profitability or even revenue potential. The accreditation will show you what products they can supply, and even that is all dependent on their ability to bring in referrals.
There is reason to invest here, and their contracting is one of them, but to treat that as if it has some unusual value or that it and of itself is value at all is rather short sighted.